Veterinary Point of Care Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Consumables, Reagents, & Kits v/s Instruments & Devices), By Animal Type {Companion Animals (Dogs, Cats, Horses, Others), Livestock Animals (Cattle, Swine, Poultry, Others), By Sample Type (Blood/Plasma/Serum, Urine, Fecal, Others), By Indication (Infectious Disease, General Ailments, Others), By Testing Category (Hematology, Diagnostic Imaging, Bacteriology, Virology, Cytology, Clinical Chemistry, Parasitology, Serology, Others), By End User (Veterinary Hospitals & Clinics, Home Care Settings, Others) By Region and Competition
The Veterinary Point of Care Diagnostics Market, valued at USD 1.51 Billion in 2022, is expected to undergo substantial growth in the forecast period, with an anticipated Compound Annual Growth Rate (CAGR) of 10.11% through 2028.
This market is currently witnessing remarkable growth, driven by a convergence of various factors. The global rise in pet ownership, combined with an increased awareness of pet health, has led to a surge in demand for rapid and convenient diagnostic solutions. Technological advancements have yielded sophisticated, user-friendly devices that provide quick and accurate results, catering to the preferences of both veterinarians and pet owners.
The prevalence of various veterinary diseases, including diabetes and infectious ailments, emphasizes the importance of timely and precise diagnoses, ultimately improving animal healthcare outcomes. Regulatory support and the expansion of veterinary clinics and hospitals further reinforce the market's growth potential. Additionally, partnerships and collaborations among diagnostic device manufacturers, veterinary facilities, and academic institutions contribute to ongoing innovation in this sector.
As cost-efficiency, telemedicine, and remote monitoring gain prominence, point-of-care diagnostics assume a pivotal role in enabling real-time health assessments. With competition driving innovation, the veterinary point-of-care diagnostics market is well-positioned for sustained growth, establishing itself as a crucial component of the broader veterinary healthcare industry.
Key Market Drivers
Increasing Pet Ownership
The increasing trend of pet ownership is a significant driving force behind the rapid growth of the veterinary point-of-care diagnostics market. This surge in pet ownership is seen across the globe and is influenced by various factors, contributing to the expansion of the market in several ways.
Firstly, the growing number of pet owners translates into a larger patient base for veterinarians. As more people open their homes to companion animals, the demand for veterinary services, including diagnostics, naturally rises. This trend is not limited to traditional pets like dogs and cats but extends to exotic pets as well, widening the market's scope.
Secondly, pet owners are increasingly viewing their pets as cherished family members, leading to a heightened awareness of the importance of maintaining their health and well-being. As a result, pet owners are more willing to invest in veterinary care, including diagnostic tests, to ensure their pets lead healthy lives. This mindset shift has created a substantial demand for point-of-care diagnostics that offer quick and accurate results, allowing for timely interventions and personalized treatment plans.
Thirdly, the emotional attachment between pet owners and their animals has led to a willingness to go the extra mile for their pets' healthcare needs. This includes regular check-ups and preventive measures, often involving point-of-care diagnostics for early disease detection. Pet owners are now more proactive in seeking out healthcare services for their pets, driving up the demand for veterinary diagnostic tools.
Additionally, the rise in pet ownership has led to an increased need for diagnostics in various settings beyond traditional veterinary clinics. Pet owners are seeking diagnostic tools that they can use at home to monitor their pets' health, especially for chronic conditions like diabetes. This has spurred innovation in the development of user-friendly, portable, and accurate point-of-care diagnostic devices that cater to both veterinary professionals and pet owners.
Prevalence of Veterinary Diseases
The prevalence of veterinary diseases plays a vital role in influencing the growth of the veterinary point-of-care diagnostics market. This factor has a significant impact on the demand for diagnostic tools and drives innovation in the field of veterinary diagnostics.
First and foremost, the increasing prevalence of various veterinary diseases, including infectious diseases, chronic conditions, and cancer among animals, necessitates regular monitoring and prompt diagnosis. As these diseases become more common, veterinarians and pet owners alike seek accurate and rapid diagnostic solutions to detect and manage these conditions at an early stage. Point-of-care diagnostics offer the advantage of timely detection, enabling quicker treatment interventions and potentially improving the prognosis for affected animals.
Moreover, the emergence of new and evolving diseases, as well as zoonotic diseases that can affect both animals and humans, underscores the importance of effective and efficient diagnostics. Point-of-care tests that can quickly identify these diseases are critical for preventing their spread and ensuring the health and safety of both animals and their human caregivers. The need for such diagnostics becomes particularly evident in cases of disease outbreaks or when monitoring diseases with public health implications.
Additionally, the rising prevalence of chronic diseases in pets, such as diabetes and kidney disease, necessitates regular monitoring and management. Point-of-care diagnostics provide a convenient way for pet owners to monitor their animals' health at home, reducing the need for frequent visits to veterinary clinics. This not only improves the quality of life for pets but also drives demand for portable diagnostic devices.
Furthermore, as the global pet trade continues to expand, the risk of disease transmission and the need for health certificates for traveling animals have become increasingly important. Point-of-care diagnostics are essential tools in verifying the health status of animals before international travel or trade, making them indispensable in facilitating global movements of animals.
Key Market Challenges
Cost Barriers
One of the key challenges facing the veterinary point-of-care diagnostics market is the issue of cost barriers. While point-of-care diagnostic devices offer numerous advantages in terms of convenience and rapid results, their development, manufacturing, and maintenance costs can pose significant challenges.
Manufacturing point-of-care diagnostic devices often involves the use of advanced technology and specialized materials, contributing to higher production costs. Additionally, ensuring the accuracy and reliability of these devices requires rigorous quality control processes, which can further increase manufacturing expenses. These costs can be especially burdensome for smaller veterinary practices and clinics with limited financial resources, potentially limiting their ability to adopt and use these advanced diagnostic tools.
Maintenance costs also play a crucial role in the overall affordability of point-of-care diagnostics. Regular calibration, servicing, and updates are necessary to keep these devices functioning optimally. Maintenance expenses can accumulate over time and may deter veterinary practices from investing in point-of-care technology, especially if they lack the budget or infrastructure to support ongoing maintenance.
The cost barrier challenge extends to pet owners as well. Some point-of-care diagnostic tests may require specialized consumables or reagents, which can be expensive. In cases where pet owners are responsible for these costs, the affordability of regular testing may become a concern, potentially limiting the frequency of diagnostics and affecting the overall health management of their pets.
Diagnostic Accuracy
Ensuring the accuracy of point-of-care diagnostics in veterinary medicine is a critical challenge. While these devices offer the advantage of rapid results and on-site testing, maintaining consistently high levels of accuracy can be complex. Factors such as variations in sample quality, operator error, and device calibration can influence the reliability of results.
One of the primary concerns is the potential for false positives or false negatives, which can have significant consequences for patient care. Misdiagnoses can lead to unnecessary treatments, increased healthcare costs, and undue stress for pet owners. Conversely, failing to detect a disease or condition can delay necessary interventions, potentially leading to worsened health outcomes for animals.
Additionally, point-of-care diagnostic devices may not always provide the same level of accuracy as laboratory-based tests, which are often considered the gold standard. This can create challenges in terms of confidence in the results and may necessitate confirmation through additional testing, which can be time-consuming and costly.
Key Market Trends
Rise in Telemedicine and Remote Monitoring
The rise of telemedicine and remote monitoring is a significant trend reshaping the landscape of veterinary point-of-care diagnostics. This trend has been accelerated by advancements in communication technology and the changing preferences of both veterinarians and pet owners.
Telemedicine in veterinary care involves the remote consultation between veterinarians and pet owners through video calls or messaging platforms. Remote monitoring, on the other hand, enables veterinarians to track an animal's health status and receive real-time data from wearable devices and at-home diagnostic kits. Point-of-care diagnostics play a pivotal role in enabling remote monitoring, as they empower pet owners to collect and share vital health data with veterinarians without the need for frequent in-person visits.
This trend offers several advantages. First, it enhances accessibility to veterinary care, particularly in remote areas or during emergencies when immediate access to a veterinary clinic may be challenging. It also reduces stress for animals that may be anxious during visits to a clinic.
Furthermore, the COVID-19 pandemic further accelerated the adoption of telemedicine and remote monitoring in veterinary care as it necessitated physical distancing measures. This crisis highlighted the potential of point-of-care diagnostics to provide essential health data remotely, ensuring continuity of care while minimizing human contact.
The integration of point-of-care diagnostics with telemedicine and remote monitoring platforms allows for real-time assessment of an animal's health, facilitating early disease detection and timely interventions. It empowers pet owners to actively participate in their pets' healthcare and provides veterinarians with a more comprehensive view of an animal's health over time.
Integration of AI and Data Analytics
The integration of artificial intelligence (AI) and data analytics is a transformative trend in the veterinary point-of-care diagnostics market. It represents a leap forward in the capabilities of diagnostic devices and their ability to provide actionable insights for veterinarians and pet owners.
AI-driven algorithms are being employed to analyze complex data generated by point-of-care diagnostic tests rapidly. This technology can identify subtle patterns and trends that may be challenging for human interpretation. For example, in image-based diagnostics, AI can detect abnormalities in radiographic images or identify specific cells in microscopic slides with a high degree of accuracy.
Data analytics, coupled with AI, enables the development of predictive models. These models can anticipate health issues based on historical data, genetic factors, and real-time inputs from diagnostic tests. This allows for early intervention and preventive measures, significantly improving the quality of care for animals.
One prominent application of AI and data analytics in veterinary diagnostics is in the interpretation of blood test results. Algorithms can quickly analyze comprehensive blood panels, considering multiple parameters such as organ function, electrolyte balance, and blood cell counts. This results in more precise and holistic assessments of an animal's health status.
Moreover, AI-driven diagnostic devices can adapt and learn from their interactions with patients and healthcare providers, continuously improving their diagnostic accuracy over time. They can provide diagnostic recommendations that consider the specific needs of an individual animal, thereby contributing to personalized medicine in veterinary care.
Segmental Insights
Product Insights
The Consumables, Reagents, & Kits dominate the Veterinary Point of Care Diagnostics market and is predicted to continue expanding over the coming years. These components are integral to the operation of diagnostic devices, and their significance lies in their consumable nature and recurring need. Firstly, consumables, reagents, and kits are essential for performing a wide range of diagnostic tests in veterinary practice. Whether it's blood tests, urine analysis, or molecular diagnostics, these components serve as the core elements that interact with samples to produce results. Veterinary professionals rely on these consumables daily to make informed decisions about animal health. Secondly, the recurring nature of consumables drives consistent demand. Veterinary clinics and laboratories require a steady supply of reagents and kits to meet the diagnostic needs of their patients. As a result, consumables form a substantial portion of the ongoing operational expenses for veterinary facilities, ensuring a reliable market for manufacturers and suppliers.
Thirdly, advancements in diagnostic technologies often involve the development of new and improved consumables, reagents, and kits. Manufacturers are continually innovating to enhance the accuracy, specificity, and ease of use of these components, thereby driving market growth through product development.
Moreover, the adoption of point-of-care diagnostics in remote and mobile veterinary services has boosted the demand for portable and convenient kits and consumables that can be easily transported and used in diverse settings.
Regional Insights
The North America region has established itself as the leader in the Veterinary Point of Care Diagnostics Market in 2022. Firstly, North America boasts a robust and well-developed veterinary healthcare infrastructure. The region is home to a large number of veterinary clinics, hospitals, and research institutions that are at the forefront of adopting advanced diagnostic technologies. This extensive network of healthcare providers creates a strong demand base for VPOC diagnostic devices and associated consumables. Secondly, the region places a high premium on pet ownership and animal health. The United States and Canada, in particular, have witnessed a substantial increase in pet ownership over the years, resulting in heightened awareness of pet healthcare needs. Pet owners in North America are more inclined to invest in cutting-edge diagnostic tools and services, contributing to the growth of the VPOC market. Additionally, North America is a hub of innovation and research in the field of veterinary medicine. Leading companies in the VPOC market, as well as academic institutions, are actively engaged in research and development efforts to create advanced diagnostic solutions. This innovation culture drives the rapid adoption of new technologies and fuels market growth. Furthermore, favorable regulatory frameworks and stringent quality standards in North America inspire confidence in VPOC diagnostic products. These regulations ensure the safety, accuracy, and reliability of diagnostic devices, fostering trust among veterinary professionals and pet owners.
Key Market Players
Zoetis Inc.
IDEXX Laboratories, Inc.
Virbac SA
Heska Corporation
Thermo Fisher Scientific, Inc
Mindray Medical International Limited
Esaote S.P.A.
FUJIFILM Corporation
Woodley Equipment Company Ltd
Report Scope:
In this report, the Veterinary Point of Care Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Veterinary Point of Care Diagnostics Market.
Available Customizations:
Veterinary Point of Care Diagnostics Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
This market is currently witnessing remarkable growth, driven by a convergence of various factors. The global rise in pet ownership, combined with an increased awareness of pet health, has led to a surge in demand for rapid and convenient diagnostic solutions. Technological advancements have yielded sophisticated, user-friendly devices that provide quick and accurate results, catering to the preferences of both veterinarians and pet owners.
The prevalence of various veterinary diseases, including diabetes and infectious ailments, emphasizes the importance of timely and precise diagnoses, ultimately improving animal healthcare outcomes. Regulatory support and the expansion of veterinary clinics and hospitals further reinforce the market's growth potential. Additionally, partnerships and collaborations among diagnostic device manufacturers, veterinary facilities, and academic institutions contribute to ongoing innovation in this sector.
As cost-efficiency, telemedicine, and remote monitoring gain prominence, point-of-care diagnostics assume a pivotal role in enabling real-time health assessments. With competition driving innovation, the veterinary point-of-care diagnostics market is well-positioned for sustained growth, establishing itself as a crucial component of the broader veterinary healthcare industry.
Key Market Drivers
Increasing Pet Ownership
The increasing trend of pet ownership is a significant driving force behind the rapid growth of the veterinary point-of-care diagnostics market. This surge in pet ownership is seen across the globe and is influenced by various factors, contributing to the expansion of the market in several ways.
Firstly, the growing number of pet owners translates into a larger patient base for veterinarians. As more people open their homes to companion animals, the demand for veterinary services, including diagnostics, naturally rises. This trend is not limited to traditional pets like dogs and cats but extends to exotic pets as well, widening the market's scope.
Secondly, pet owners are increasingly viewing their pets as cherished family members, leading to a heightened awareness of the importance of maintaining their health and well-being. As a result, pet owners are more willing to invest in veterinary care, including diagnostic tests, to ensure their pets lead healthy lives. This mindset shift has created a substantial demand for point-of-care diagnostics that offer quick and accurate results, allowing for timely interventions and personalized treatment plans.
Thirdly, the emotional attachment between pet owners and their animals has led to a willingness to go the extra mile for their pets' healthcare needs. This includes regular check-ups and preventive measures, often involving point-of-care diagnostics for early disease detection. Pet owners are now more proactive in seeking out healthcare services for their pets, driving up the demand for veterinary diagnostic tools.
Additionally, the rise in pet ownership has led to an increased need for diagnostics in various settings beyond traditional veterinary clinics. Pet owners are seeking diagnostic tools that they can use at home to monitor their pets' health, especially for chronic conditions like diabetes. This has spurred innovation in the development of user-friendly, portable, and accurate point-of-care diagnostic devices that cater to both veterinary professionals and pet owners.
Prevalence of Veterinary Diseases
The prevalence of veterinary diseases plays a vital role in influencing the growth of the veterinary point-of-care diagnostics market. This factor has a significant impact on the demand for diagnostic tools and drives innovation in the field of veterinary diagnostics.
First and foremost, the increasing prevalence of various veterinary diseases, including infectious diseases, chronic conditions, and cancer among animals, necessitates regular monitoring and prompt diagnosis. As these diseases become more common, veterinarians and pet owners alike seek accurate and rapid diagnostic solutions to detect and manage these conditions at an early stage. Point-of-care diagnostics offer the advantage of timely detection, enabling quicker treatment interventions and potentially improving the prognosis for affected animals.
Moreover, the emergence of new and evolving diseases, as well as zoonotic diseases that can affect both animals and humans, underscores the importance of effective and efficient diagnostics. Point-of-care tests that can quickly identify these diseases are critical for preventing their spread and ensuring the health and safety of both animals and their human caregivers. The need for such diagnostics becomes particularly evident in cases of disease outbreaks or when monitoring diseases with public health implications.
Additionally, the rising prevalence of chronic diseases in pets, such as diabetes and kidney disease, necessitates regular monitoring and management. Point-of-care diagnostics provide a convenient way for pet owners to monitor their animals' health at home, reducing the need for frequent visits to veterinary clinics. This not only improves the quality of life for pets but also drives demand for portable diagnostic devices.
Furthermore, as the global pet trade continues to expand, the risk of disease transmission and the need for health certificates for traveling animals have become increasingly important. Point-of-care diagnostics are essential tools in verifying the health status of animals before international travel or trade, making them indispensable in facilitating global movements of animals.
Key Market Challenges
Cost Barriers
One of the key challenges facing the veterinary point-of-care diagnostics market is the issue of cost barriers. While point-of-care diagnostic devices offer numerous advantages in terms of convenience and rapid results, their development, manufacturing, and maintenance costs can pose significant challenges.
Manufacturing point-of-care diagnostic devices often involves the use of advanced technology and specialized materials, contributing to higher production costs. Additionally, ensuring the accuracy and reliability of these devices requires rigorous quality control processes, which can further increase manufacturing expenses. These costs can be especially burdensome for smaller veterinary practices and clinics with limited financial resources, potentially limiting their ability to adopt and use these advanced diagnostic tools.
Maintenance costs also play a crucial role in the overall affordability of point-of-care diagnostics. Regular calibration, servicing, and updates are necessary to keep these devices functioning optimally. Maintenance expenses can accumulate over time and may deter veterinary practices from investing in point-of-care technology, especially if they lack the budget or infrastructure to support ongoing maintenance.
The cost barrier challenge extends to pet owners as well. Some point-of-care diagnostic tests may require specialized consumables or reagents, which can be expensive. In cases where pet owners are responsible for these costs, the affordability of regular testing may become a concern, potentially limiting the frequency of diagnostics and affecting the overall health management of their pets.
Diagnostic Accuracy
Ensuring the accuracy of point-of-care diagnostics in veterinary medicine is a critical challenge. While these devices offer the advantage of rapid results and on-site testing, maintaining consistently high levels of accuracy can be complex. Factors such as variations in sample quality, operator error, and device calibration can influence the reliability of results.
One of the primary concerns is the potential for false positives or false negatives, which can have significant consequences for patient care. Misdiagnoses can lead to unnecessary treatments, increased healthcare costs, and undue stress for pet owners. Conversely, failing to detect a disease or condition can delay necessary interventions, potentially leading to worsened health outcomes for animals.
Additionally, point-of-care diagnostic devices may not always provide the same level of accuracy as laboratory-based tests, which are often considered the gold standard. This can create challenges in terms of confidence in the results and may necessitate confirmation through additional testing, which can be time-consuming and costly.
Key Market Trends
Rise in Telemedicine and Remote Monitoring
The rise of telemedicine and remote monitoring is a significant trend reshaping the landscape of veterinary point-of-care diagnostics. This trend has been accelerated by advancements in communication technology and the changing preferences of both veterinarians and pet owners.
Telemedicine in veterinary care involves the remote consultation between veterinarians and pet owners through video calls or messaging platforms. Remote monitoring, on the other hand, enables veterinarians to track an animal's health status and receive real-time data from wearable devices and at-home diagnostic kits. Point-of-care diagnostics play a pivotal role in enabling remote monitoring, as they empower pet owners to collect and share vital health data with veterinarians without the need for frequent in-person visits.
This trend offers several advantages. First, it enhances accessibility to veterinary care, particularly in remote areas or during emergencies when immediate access to a veterinary clinic may be challenging. It also reduces stress for animals that may be anxious during visits to a clinic.
Furthermore, the COVID-19 pandemic further accelerated the adoption of telemedicine and remote monitoring in veterinary care as it necessitated physical distancing measures. This crisis highlighted the potential of point-of-care diagnostics to provide essential health data remotely, ensuring continuity of care while minimizing human contact.
The integration of point-of-care diagnostics with telemedicine and remote monitoring platforms allows for real-time assessment of an animal's health, facilitating early disease detection and timely interventions. It empowers pet owners to actively participate in their pets' healthcare and provides veterinarians with a more comprehensive view of an animal's health over time.
Integration of AI and Data Analytics
The integration of artificial intelligence (AI) and data analytics is a transformative trend in the veterinary point-of-care diagnostics market. It represents a leap forward in the capabilities of diagnostic devices and their ability to provide actionable insights for veterinarians and pet owners.
AI-driven algorithms are being employed to analyze complex data generated by point-of-care diagnostic tests rapidly. This technology can identify subtle patterns and trends that may be challenging for human interpretation. For example, in image-based diagnostics, AI can detect abnormalities in radiographic images or identify specific cells in microscopic slides with a high degree of accuracy.
Data analytics, coupled with AI, enables the development of predictive models. These models can anticipate health issues based on historical data, genetic factors, and real-time inputs from diagnostic tests. This allows for early intervention and preventive measures, significantly improving the quality of care for animals.
One prominent application of AI and data analytics in veterinary diagnostics is in the interpretation of blood test results. Algorithms can quickly analyze comprehensive blood panels, considering multiple parameters such as organ function, electrolyte balance, and blood cell counts. This results in more precise and holistic assessments of an animal's health status.
Moreover, AI-driven diagnostic devices can adapt and learn from their interactions with patients and healthcare providers, continuously improving their diagnostic accuracy over time. They can provide diagnostic recommendations that consider the specific needs of an individual animal, thereby contributing to personalized medicine in veterinary care.
Segmental Insights
Product Insights
The Consumables, Reagents, & Kits dominate the Veterinary Point of Care Diagnostics market and is predicted to continue expanding over the coming years. These components are integral to the operation of diagnostic devices, and their significance lies in their consumable nature and recurring need. Firstly, consumables, reagents, and kits are essential for performing a wide range of diagnostic tests in veterinary practice. Whether it's blood tests, urine analysis, or molecular diagnostics, these components serve as the core elements that interact with samples to produce results. Veterinary professionals rely on these consumables daily to make informed decisions about animal health. Secondly, the recurring nature of consumables drives consistent demand. Veterinary clinics and laboratories require a steady supply of reagents and kits to meet the diagnostic needs of their patients. As a result, consumables form a substantial portion of the ongoing operational expenses for veterinary facilities, ensuring a reliable market for manufacturers and suppliers.
Thirdly, advancements in diagnostic technologies often involve the development of new and improved consumables, reagents, and kits. Manufacturers are continually innovating to enhance the accuracy, specificity, and ease of use of these components, thereby driving market growth through product development.
Moreover, the adoption of point-of-care diagnostics in remote and mobile veterinary services has boosted the demand for portable and convenient kits and consumables that can be easily transported and used in diverse settings.
Regional Insights
The North America region has established itself as the leader in the Veterinary Point of Care Diagnostics Market in 2022. Firstly, North America boasts a robust and well-developed veterinary healthcare infrastructure. The region is home to a large number of veterinary clinics, hospitals, and research institutions that are at the forefront of adopting advanced diagnostic technologies. This extensive network of healthcare providers creates a strong demand base for VPOC diagnostic devices and associated consumables. Secondly, the region places a high premium on pet ownership and animal health. The United States and Canada, in particular, have witnessed a substantial increase in pet ownership over the years, resulting in heightened awareness of pet healthcare needs. Pet owners in North America are more inclined to invest in cutting-edge diagnostic tools and services, contributing to the growth of the VPOC market. Additionally, North America is a hub of innovation and research in the field of veterinary medicine. Leading companies in the VPOC market, as well as academic institutions, are actively engaged in research and development efforts to create advanced diagnostic solutions. This innovation culture drives the rapid adoption of new technologies and fuels market growth. Furthermore, favorable regulatory frameworks and stringent quality standards in North America inspire confidence in VPOC diagnostic products. These regulations ensure the safety, accuracy, and reliability of diagnostic devices, fostering trust among veterinary professionals and pet owners.
Key Market Players
Zoetis Inc.
IDEXX Laboratories, Inc.
Virbac SA
Heska Corporation
Thermo Fisher Scientific, Inc
Mindray Medical International Limited
Esaote S.P.A.
FUJIFILM Corporation
Woodley Equipment Company Ltd
Report Scope:
In this report, the Veterinary Point of Care Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Veterinary Point of Care Diagnostics Market, Product:
- Short PIVCs
- Huber Needles
- Midline Catheters
- PICCs
- CVCs
- Dialysis Catheters
- Implantable Ports
- Veterinary Point of Care Diagnostics Market, Animal Type:
- Companion Animals
- Livestock Animals
- Veterinary Point of Care Diagnostics Market, Sample Type:
- Blood/Plasma/Serum
- Urine
- Fecal
- Others
- Veterinary Point of Care Diagnostics Market, Indication:
- Infectious Disease
- General Ailments
- Others
- Veterinary Point of Care Diagnostics Market, Testing Category:
- Hematology
- Diagnostic Imaging
- Bacteriology
- Virology
- Cytology
- Clinical Chemistry
- Parasitology
- Serology
- Others
- Veterinary Point of Care Diagnostics Market, End User:
- Veterinary Hospitals & Clinics
- Home Care Settings
- Others
- Veterinary Point of Care Diagnostics Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Veterinary Point of Care Diagnostics Market.
Available Customizations:
Veterinary Point of Care Diagnostics Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Consumables, Reagents, & Kits v/s Instruments & Devices)
5.2.2. By Animal Type {Companion Animals (Dogs, Cats, Horses, Others), Livestock Animals (Cattle, Swine, Poultry, Others)
5.2.3. By Sample Type (Blood/Plasma/Serum, Urine, Fecal, Others)
5.2.4. By Indication (Infectious Disease, General Ailments, Others)
5.2.5. By Testing Category (Hematology, Diagnostic Imaging, Bacteriology, Virology, Cytology, Clinical Chemistry, Parasitology, Serology, Others)
5.2.6. By End User (Veterinary Hospitals & Clinics, Home Care Settings, Others)
5.2.7. By Region
5.2.8. By Company (2022)
5.3. Market Map
6. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Animal Type
6.2.3. By Sample Type
6.2.4. By Indication
6.2.5. By Testing Category
6.2.6. By End User
6.2.7. By Country
6.3. North America: Country Analysis
6.3.1. United States Veterinary Point of Care Diagnostics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Animal Type
6.3.1.2.3. By Sample Type
6.3.1.2.4. By Indication
6.3.1.2.5. By Testing Category
6.3.1.2.6. By End User
6.3.2. Canada Veterinary Point of Care Diagnostics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Animal Type
6.3.2.2.3. By Sample Type
6.3.2.2.4. By Indication
6.3.2.2.5. By Testing Category
6.3.2.2.6. By End User
6.3.3. Mexico Veterinary Point of Care Diagnostics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Animal Type
6.3.3.2.3. By Sample Type
6.3.3.2.4. By Indication
6.3.3.2.5. By Testing Category
6.3.3.2.6. By End User
7. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Animal Type
7.2.3. By Sample Type
7.2.4. By Indication
7.2.5. By Testing Category
7.2.6. By End User
7.2.7. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Veterinary Point of Care Diagnostics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Animal Type
7.3.1.2.3. By Sample Type
7.3.1.2.4. By Indication
7.3.1.2.5. By Testing Category
7.3.1.2.6. By End User
7.3.2. United Kingdom Veterinary Point of Care Diagnostics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Animal Type
7.3.2.2.3. By Sample Type
7.3.2.2.4. By Indication
7.3.2.2.5. By Testing Category
7.3.2.2.6. By End User
7.3.3. Italy Veterinary Point of Care Diagnostics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Product
7.3.3.2.2. By Animal Type
7.3.3.2.3. By Sample Type
7.3.3.2.4. By Indication
7.3.3.2.5. By Testing Category
7.3.3.2.6. By End User
7.3.4. France Veterinary Point of Care Diagnostics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Animal Type
7.3.4.2.3. By Sample Type
7.3.4.2.4. By Indication
7.3.4.2.5. By Testing Category
7.3.4.2.6. By End User
7.3.5. Spain Veterinary Point of Care Diagnostics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Animal Type
7.3.5.2.3. By Sample Type
7.3.5.2.4. By Indication
7.3.5.2.5. By Testing Category
7.3.5.2.6. By End User
8. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Animal Type
8.2.3. By Sample Type
8.2.4. By Indication
8.2.5. By Testing Category
8.2.6. By End User
8.2.7. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Veterinary Point of Care Diagnostics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Animal Type
8.3.1.2.3. By Sample Type
8.3.1.2.4. By Indication
8.3.1.2.5. By Testing Category
8.3.1.2.6. By End User
8.3.2. India Veterinary Point of Care Diagnostics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Animal Type
8.3.2.2.3. By Sample Type
8.3.2.2.4. By Indication
8.3.2.2.5. By Testing Category
8.3.2.2.6. By End User
8.3.3. Japan Veterinary Point of Care Diagnostics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Animal Type
8.3.3.2.3. By Sample Type
8.3.3.2.4. By Indication
8.3.3.2.5. By Testing Category
8.3.3.2.6. By End User
8.3.4. South Korea Veterinary Point of Care Diagnostics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Animal Type
8.3.4.2.3. By Sample Type
8.3.4.2.4. By Indication
8.3.4.2.5. By Testing Category
8.3.4.2.6. By End User
8.3.5. Australia Veterinary Point of Care Diagnostics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Animal Type
8.3.5.2.3. By Sample Type
8.3.5.2.4. By Indication
8.3.5.2.5. By Testing Category
8.3.5.2.6. By End User
9. SOUTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Animal Type
9.2.3. By Sample Type
9.2.4. By Indication
9.2.5. By Testing Category
9.2.6. By End User
9.2.7. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Veterinary Point of Care Diagnostics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Animal Type
9.3.1.2.3. By Sample Type
9.3.1.2.4. By Indication
9.3.1.2.5. By Testing Category
9.3.1.2.6. By End User
9.3.2. Argentina Veterinary Point of Care Diagnostics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Animal Type
9.3.2.2.3. By Sample Type
9.3.2.2.4. By Indication
9.3.2.2.5. By Testing Category
9.3.2.2.6. By End User
9.3.3. Colombia Veterinary Point of Care Diagnostics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Animal Type
9.3.3.2.3. By Sample Type
9.3.3.2.4. By Indication
9.3.3.2.5. By Testing Category
9.3.3.2.6. By End User
10. MIDDLE EAST AND AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Animal Type
10.2.3. By Sample Type
10.2.4. By Indication
10.2.5. By Testing Category
10.2.6. By End User
10.2.7. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Veterinary Point of Care Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Animal Type
10.3.1.2.3. By Sample Type
10.3.1.2.4. By Indication
10.3.1.2.5. By Testing Category
10.3.1.2.6. By End User
10.3.2. Saudi Arabia Veterinary Point of Care Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Animal Type
10.3.2.2.3. By Sample Type
10.3.2.2.4. By Indication
10.3.2.2.5. By Testing Category
10.3.2.2.6. By End User
10.3.3. UAE Veterinary Point of Care Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Animal Type
10.3.3.2.3. By Sample Type
10.3.3.2.4. By Indication
10.3.3.2.5. By Testing Category
10.3.3.2.6. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
13. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET: SWOT ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Treatment Types
15. COMPETITIVE LANDSCAPE
15.1. Business Overview
15.2. Service Offerings
15.3. Recent Developments
15.4. Key Personnel
15.5. SWOT Analysis
15.5.1. Zoetis Inc.
15.5.2. IDEXX Laboratories, Inc.
15.5.3. Virbac SA
15.5.4. Heska Corporation
15.5.5. Thermo Fisher Scientific, Inc
15.5.6. Mindray Medical International Limited
15.5.7. Esaote S.P.A.
15.5.8. FUJIFILM Corporation
15.5.9. Woodley Equipment Company Ltd
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Consumables, Reagents, & Kits v/s Instruments & Devices)
5.2.2. By Animal Type {Companion Animals (Dogs, Cats, Horses, Others), Livestock Animals (Cattle, Swine, Poultry, Others)
5.2.3. By Sample Type (Blood/Plasma/Serum, Urine, Fecal, Others)
5.2.4. By Indication (Infectious Disease, General Ailments, Others)
5.2.5. By Testing Category (Hematology, Diagnostic Imaging, Bacteriology, Virology, Cytology, Clinical Chemistry, Parasitology, Serology, Others)
5.2.6. By End User (Veterinary Hospitals & Clinics, Home Care Settings, Others)
5.2.7. By Region
5.2.8. By Company (2022)
5.3. Market Map
6. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Animal Type
6.2.3. By Sample Type
6.2.4. By Indication
6.2.5. By Testing Category
6.2.6. By End User
6.2.7. By Country
6.3. North America: Country Analysis
6.3.1. United States Veterinary Point of Care Diagnostics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Animal Type
6.3.1.2.3. By Sample Type
6.3.1.2.4. By Indication
6.3.1.2.5. By Testing Category
6.3.1.2.6. By End User
6.3.2. Canada Veterinary Point of Care Diagnostics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Animal Type
6.3.2.2.3. By Sample Type
6.3.2.2.4. By Indication
6.3.2.2.5. By Testing Category
6.3.2.2.6. By End User
6.3.3. Mexico Veterinary Point of Care Diagnostics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Animal Type
6.3.3.2.3. By Sample Type
6.3.3.2.4. By Indication
6.3.3.2.5. By Testing Category
6.3.3.2.6. By End User
7. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Animal Type
7.2.3. By Sample Type
7.2.4. By Indication
7.2.5. By Testing Category
7.2.6. By End User
7.2.7. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Veterinary Point of Care Diagnostics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Animal Type
7.3.1.2.3. By Sample Type
7.3.1.2.4. By Indication
7.3.1.2.5. By Testing Category
7.3.1.2.6. By End User
7.3.2. United Kingdom Veterinary Point of Care Diagnostics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Animal Type
7.3.2.2.3. By Sample Type
7.3.2.2.4. By Indication
7.3.2.2.5. By Testing Category
7.3.2.2.6. By End User
7.3.3. Italy Veterinary Point of Care Diagnostics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Product
7.3.3.2.2. By Animal Type
7.3.3.2.3. By Sample Type
7.3.3.2.4. By Indication
7.3.3.2.5. By Testing Category
7.3.3.2.6. By End User
7.3.4. France Veterinary Point of Care Diagnostics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Animal Type
7.3.4.2.3. By Sample Type
7.3.4.2.4. By Indication
7.3.4.2.5. By Testing Category
7.3.4.2.6. By End User
7.3.5. Spain Veterinary Point of Care Diagnostics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Animal Type
7.3.5.2.3. By Sample Type
7.3.5.2.4. By Indication
7.3.5.2.5. By Testing Category
7.3.5.2.6. By End User
8. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Animal Type
8.2.3. By Sample Type
8.2.4. By Indication
8.2.5. By Testing Category
8.2.6. By End User
8.2.7. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Veterinary Point of Care Diagnostics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Animal Type
8.3.1.2.3. By Sample Type
8.3.1.2.4. By Indication
8.3.1.2.5. By Testing Category
8.3.1.2.6. By End User
8.3.2. India Veterinary Point of Care Diagnostics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Animal Type
8.3.2.2.3. By Sample Type
8.3.2.2.4. By Indication
8.3.2.2.5. By Testing Category
8.3.2.2.6. By End User
8.3.3. Japan Veterinary Point of Care Diagnostics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Animal Type
8.3.3.2.3. By Sample Type
8.3.3.2.4. By Indication
8.3.3.2.5. By Testing Category
8.3.3.2.6. By End User
8.3.4. South Korea Veterinary Point of Care Diagnostics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Animal Type
8.3.4.2.3. By Sample Type
8.3.4.2.4. By Indication
8.3.4.2.5. By Testing Category
8.3.4.2.6. By End User
8.3.5. Australia Veterinary Point of Care Diagnostics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Animal Type
8.3.5.2.3. By Sample Type
8.3.5.2.4. By Indication
8.3.5.2.5. By Testing Category
8.3.5.2.6. By End User
9. SOUTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Animal Type
9.2.3. By Sample Type
9.2.4. By Indication
9.2.5. By Testing Category
9.2.6. By End User
9.2.7. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Veterinary Point of Care Diagnostics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Animal Type
9.3.1.2.3. By Sample Type
9.3.1.2.4. By Indication
9.3.1.2.5. By Testing Category
9.3.1.2.6. By End User
9.3.2. Argentina Veterinary Point of Care Diagnostics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Animal Type
9.3.2.2.3. By Sample Type
9.3.2.2.4. By Indication
9.3.2.2.5. By Testing Category
9.3.2.2.6. By End User
9.3.3. Colombia Veterinary Point of Care Diagnostics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Animal Type
9.3.3.2.3. By Sample Type
9.3.3.2.4. By Indication
9.3.3.2.5. By Testing Category
9.3.3.2.6. By End User
10. MIDDLE EAST AND AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Animal Type
10.2.3. By Sample Type
10.2.4. By Indication
10.2.5. By Testing Category
10.2.6. By End User
10.2.7. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Veterinary Point of Care Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Animal Type
10.3.1.2.3. By Sample Type
10.3.1.2.4. By Indication
10.3.1.2.5. By Testing Category
10.3.1.2.6. By End User
10.3.2. Saudi Arabia Veterinary Point of Care Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Animal Type
10.3.2.2.3. By Sample Type
10.3.2.2.4. By Indication
10.3.2.2.5. By Testing Category
10.3.2.2.6. By End User
10.3.3. UAE Veterinary Point of Care Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Animal Type
10.3.3.2.3. By Sample Type
10.3.3.2.4. By Indication
10.3.3.2.5. By Testing Category
10.3.3.2.6. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
13. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET: SWOT ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Treatment Types
15. COMPETITIVE LANDSCAPE
15.1. Business Overview
15.2. Service Offerings
15.3. Recent Developments
15.4. Key Personnel
15.5. SWOT Analysis
15.5.1. Zoetis Inc.
15.5.2. IDEXX Laboratories, Inc.
15.5.3. Virbac SA
15.5.4. Heska Corporation
15.5.5. Thermo Fisher Scientific, Inc
15.5.6. Mindray Medical International Limited
15.5.7. Esaote S.P.A.
15.5.8. FUJIFILM Corporation
15.5.9. Woodley Equipment Company Ltd
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
